Zobrazeno 1 - 10
of 566
pro vyhledávání: '"S. Faye"'
Autor:
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S. Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-5 (2023)
Abstract In the UK, the Medicines and Healthcare products Regulatory Agency consulted on proposals “to improve and strengthen the UK clinical trials legislation to help us make the UK the best place to research and develop safe and innovative medic
Externí odkaz:
https://doaj.org/article/b3bab057419146f7a2a0ab4aaefdc771
Publikováno v:
Diagnostic and Prognostic Research, Vol 7, Iss 1, Pp 1-24 (2023)
Abstract Background In a pandemic setting, it is critical to evaluate and deploy accurate diagnostic tests rapidly. This relies heavily on the sample size chosen to assess the test accuracy (e.g. sensitivity and specificity) during the diagnostic acc
Externí odkaz:
https://doaj.org/article/b2eb145834c94378b89b29bbbba999e2
Autor:
Martin Law, Dominique-Laurent Couturier, Babak Choodari-Oskooei, Phillip Crout, Carrol Gamble, Peter Jacko, Philip Pallmann, Mark Pilling, David S. Robertson, Michael Robling, Matthew R. Sydes, Sofía S. Villar, James Wason, Graham Wheeler, S. Faye Williamson, Christina Yap, Thomas Jaki
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/40c2eed3118c4c9da008c2e610d68b01
Sample size determination for cluster randomised trials (CRTs) is challenging as it requires robust estimation of the intra-cluster correlation coefficient (ICC). Typically, the sample size is chosen to provide a certain level of power to reject the
Externí odkaz:
http://arxiv.org/abs/2308.11278
Autor:
Cherlin, Svetlana, Bigirumurame, Theophile, Grayling, Michael J, Nsengimana, Jérémie, Ouma, Luke, Santaolalla, Aida, Wan, Fang, Williamson, S Faye, Wason, James M S
Introduction: Even in effectively conducted randomised trials, the probability of a successful study remains relatively low. With recent advances in the next-generation sequencing technologies, there is a rapidly growing number of high-dimensional da
Externí odkaz:
http://arxiv.org/abs/2305.10174
Autor:
Wilson, Kevin J., Williamson, S. Faye, Allen, A. Joy, Williams, Cameron J., Hellyer, Thomas P., Lendrem, B. Clare
The development of a new diagnostic test ideally follows a sequence of stages which, amongst other aims, evaluate technical performance. This includes an analytical validity study, a diagnostic accuracy study and an interventional clinical utility st
Externí odkaz:
http://arxiv.org/abs/2108.08594
Autor:
Stallard, Nigel, Hampson, Lisa, Benda, Norbert, Brannath, Werner, Burnett, Tom, Friede, Tim, Kimani, Peter K., Koenig, Franz, Krisam, Johannes, Mozgunov, Pavel, Posch, Martin, Wason, James, Wassmer, Gernot, Whitehead, John, Williamson, S. Faye, Zohar, Sarah, Jaki, Thomas
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therapies for COVID-19. The results
Externí odkaz:
http://arxiv.org/abs/2005.13309
Autor:
Williamson, S. Faye, Grayling, Michael J., Mander, Adrian P., Noor, Nurulamin M., Savage, Joshua S., Yap, Christina, Wason, James M.S.
Publikováno v:
In Journal of Clinical Epidemiology October 2022 150:72-79
Publikováno v:
In Computational Statistics and Data Analysis October 2022 174
Autor:
Zhang, Danwei, Duran, Solco S. Faye, Lim, Wei Yang Samuel, Tan, Chee Kiang Ivan, Cheong, Wun Chet Davy, Suwardi, Ady, Loh, Xian Jun
Publikováno v:
In Materials Today Advances March 2022 13